Learning your Alzheimer’s risk: Implications for long-term care insurance
In the Journal of Law, Medicine, & Ethics, Penn Medicine's Jalayne Arias, Jason Karlawish, and colleagues analyze whether, under current state laws, insurers could use Alzheimer's predictive biomarkers to deny coverage, and Penn Law's Allison Hoffman examines the lack long-term care insurance.
FULL STORY AT Leonard Davis Institute →